ATLANTA--(BUSINESS WIRE)--Incumaker, Inc. (OTC Pinks:QMKR) announced today that it had completed the acquisition of CryoMist I, LLC and CryoMist II, LLC (collectively, “CryoMist”) with a third acquisition of CryoMist III, LLC planned to close by early 2014. CryoMist is on the forefront of Cryogenic Therapy which is the general use of low temperatures in medical therapy. CryoMist stimulates the body's natural healing abilities with extreme cold to induce responses on three levels: the Circulatory System, the Energy Meridians and the Nervous System. This elicits a powerful, positive and holistic response.
Ice or cold therapy has been used since the seventeenth century to decrease cellular metabolism, increase cellular survival, decrease inflammation, and promote vasoconstriction, and decrease pain and spasms. Using a unique nitrogen fueled chamber to lower the temperature surrounding the client, the CryoMist apparatus rapidly lowers the skin’s temperature to 32°F while cabin temperature drops to a range of -270°F to -290°F below zero. CryoMist is focusing on the treatment of pain and inflammation from Sports Injuries, Fibromyalgia, Rheumatoid Arthritis, Multiple Sclerosis and skin conditions like Psoriasis and Dermatitis.
CryoMist treatments are administered individually for up to three minutes. Due to the extreme cold, the brain stimulates the body's organ regulatory functions resulting in energy increase, cell rejuvenation, immune system boost, and overall system self-healing. Studies have shown that following each treatment increased metabolism burns from 500 to 800 calories over the next several hours. Additionally, anti-aging benefits due to the production of collagen have been shown in many cases. White papers demonstrating the results can be viewed through links on our website www.cryomist.net.
The future business direction of the CryoMist division of Incumaker is the planned opening of numerous centers to provide the public access to this therapy, which to date has been primarily housed within the recovery centers of professional athletic teams located throughout the world. The two CryoMist facilities acquired as discussed above are located in Johns Creek, Georgia and Winter Garden, Florida.
Along with the acquisitions above which were affected pursuant to a Share Exchange Agreement, Incumaker has engaged an experienced team of professionals with the goal of returning the public company to fully-reporting status with the SEC.
For additional information visit the CryoMist website at www.cryomist.net or please email Investorinformation@incumaker.net.
This Press Release includes forward-looking statements. In particular, the words "believe," "may," "could," "should," "expect," "anticipate," "estimate," "project," "propose," "plan," "intend," and similar conditional words and expressions are intended to identify forward-looking statements. Any statements made in this news release about an action, event or development, are forward-looking statements. Such statements are based upon assumptions that in the future may prove not to have been accurate and are subject to significant risks and uncertainties. Such statements are subject to a number of assumptions, risks and uncertainties, many of which are beyond the control of the company. Accordingly, you should not place undue reliance on these forward-looking statements. Although the company believes that the expectations reflected in the forward-looking statements are reasonable, it can give no assurance that its forward-looking statements will prove to be correct. Investors are cautioned that any forward-looking statements are not guarantees of future performance and actual results or developments may differ materially from those projected. The forward-looking statements in this press release are made as of the date hereof. The company takes no obligation to update or correct its own forward-looking statements, except as required by law or those prepared by third parties that are not paid by the company.
